Jianping Wang

机构：Sun Yat-sen University, Sixth Affiliated Hospital of Sun Yat-sen University, Inner Mongolia People's Hospital, Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University · ORCID：0000-0002-7522-7539

发表论文 303 篇 · 总被引 10639 次 · h-index 43

代表论文

• Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer (2025 · JAMA · 被引 35)
• Research on the construction process of supply chain ecosystem led by digital platform enterprises from the perspective of dynamic capability (2024 · Supply Chain Management An International Journal · 被引 26)
• Daratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease results (2025 · Blood · 被引 23)
• Excessive vigorous exercise impairs cognitive function through a muscle-derived mitochondrial pretender (2025 · Cell Metabolism · 被引 15)
• Phase 3 Randomized Study of Daratumumab (DARA) + Bortezomib, Lenalidomide and Dexamethasone (VRd) Versus Alone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma or for Whom Transplant Is Not Planned As Initial Therapy: Analysis of Minimal Residual Disease in the Cepheus Trial (2024 · Blood · 被引 12)
• Node-sparing modified short-course Radiotherapy Combined with CAPOX and Tislelizumab for locally Advanced MSS of Middle and low rectal Cancer (mRCAT): an open-label, single-arm, prospective, multicentre clinical trial (2024 · BMC Cancer · 被引 6)